Visual Assessment and Imaging

The ability to assess structure and function of the eye in astonishing detail via medical imaging has been at the centre of much of our innovation. Increasingly, we seek to exploit this potential not just for ocular disease but also many other central nervous system (CNS) and systemic disorders.

Our research in assessment and imaging aims to improve diagnostics, provide new treatments and tools to evaluate treatment effectiveness for sight loss and neurodegenerative conditions. We are striving to reduce the burden of disease on patients and on society.


1. Develop new visual assessment tests proving more accurate and precise measurements of damage

2. Develop new imaging devices

3. Develop techniques to provide insight into disease pathophysiology and treatment response

4. Develop data analytical techniques

AIM 1 - We are striving to reduce the burden of eye and neurodegenerative disease through innovations in imaging, vision science and engineering. We are establishing new visual assessment tests for infants and children (using eye movement responses) as well as other novel assessment techniques in adults.

AIM 2 - We are developing new tools to improve the diagnosis of eye and neurodegenerative diseases. Rapid advances in the technology we are developing alongside the revolution in mobile communications is providing us with a path to change the way that care is delivered.

AIM 4 - We are working with our partners to address statistical testing in image and genomic data. Our approach, including primary care and epidemiologic data will give unparalleled insight into lifestyle and genetic determinants of ocular, cardiovascular and neurologic disease. We are also working on projects to discover relationships between AMD and cardiovascular disease.